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INTRODUCTION	  
Myalgic encephalomyelitis and chronic fatigue 
syndrome (ME and CFS) are elusive illnesses 
with controversial etiologies (Afari & 
Buchwald, 2014). While numerous case 
definitions exist (Carruthers et al., 2003; 
Carruthers et al., 2011; Fukuda et al., 1994), ME 
and CFS are characterized by a variety of core 
symptoms including profound fatigue, post-
exertional malaise, impairment of memory and 
concentration, unrefreshing sleep, arthralgia 
and/or myalgia, and several autonomic, 
neuroendocrine, and immune manifestations 
(Carruthers et al., 2003). Patients often report an 
infectious onset, stress-related onset, or a 
	  
ABSTRACT	   This study examined how the mode of onset for myalgic encephalomyelitis and 
chronic fatigue syndrome (ME and CFS) impacts patients’ presenting symptomatology. Specifically, 
this study investigated the differences between the most commonly reported ME and CFS onsets: 
infectious, stress-related, and a combined infectious and stress-related onset (referred to as ‘combined 
onset’). Three patient samples were combined and utilized. All participants met Fukuda et al. (1994) 
criteria and self-reported their illness onset. Analyses showed the infectious group reported the most 
impairment for general health functioning—which relates to the susceptibility of getting or feeling 
sick—in comparison to the stress-related group. Meanwhile, both the stress-related and combined 
groups reported more impairment for mental health functioning than the infectious group. Lastly, the 
infectious and combined groups reported worse autonomic and immune symptomatology than the 
stress group. These findings illustrate that the mode of onset for ME and CFS could play a factor in a 
patient’s prognosis. An infectious onset might lead to worse physical and somatic symptoms, while a 
stress onset might lead to worse psychological functioning. These findings are consistent with prior 
research. Future research should continue investigating the differences among patients based on illness 
onset, as well as other factors (e.g., psychiatric co-morbidity).	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  combined infectious and stress-related onset 
(Becker, McGregor, & Meirleirxy, 2002). 
Within these different patient groups, various 
ME and CFS sub-types might exist (Jason et al., 
2001). Therefore, research should examine how 
the symptomatology of these sub-types differs, 
as treatments could be tailored to patients 
accordingly. This study investigates how the 
mode of illness onset for ME and CFS affects 
the presenting symptomatology and 
functionality of patients.	  
An infectious onset of ME and CFS is defined 
by a patient having a transferrable illness (e.g. 
Epstein-Barr virus) prior to contracting ME or 
CFS. Infectious onsets have been referred to as 
sudden events, and people with this type of onset 
are more likely to attribute their illness to a 
physical cause (Butler, Chalder, & Wessely, 
2001; Komaroff, 1988). One study found a 
greater likelihood for this group to be socially 
extraverted before their illness (Masuda, 
Munemoto, Yamanaka, Takei, & Tei, 2002). 
Research has shown physical attributions to be 
more often reported than psychological 
attributions (Butler et al., 2001; White, Lehman, 
Hemphill, Mandel, & Lehman, 2006). An 
infectious onset may also lead to worse 
functional impairment (Sharpe, Hawton, 
Seagroatt, & Pasvol, 1992), worse memory 
problems, (DeLuca, Johnson, Ellis, & Natelson, 
1997), and a decreased likelihood of 
improvement over time (Vercoulen et al., 1996).  
 
Over the years, three families of viruses—herpes 
viruses, enteroviruses, and retroviruses—have 
been studied, but identifying a single infectious, 
etiological agent for ME and CFS has been 
inconclusive (Lorusso et al., 2009). Investigators 
have posited that some pathophysiological 
anomalies may precipitate or perpetuate ME and 
CFS, but the illness is likely multi-faceted. An 
aggregate of immunological studies suggests a 
“hit and run” effect, where a patient contracts a 
virus that causes immune abnormalities, which 
then leads to ME and CFS; however, when the 
virus is eliminated, the patient’s immune system 
remains in an activated state (Lorusso et al., 
2009).While no single etiological agent has been 
determined, many patients attribute their illness 
solely to an infection, and thus, research should 
continue comparing their prognosis to those of 
patients with other onset modes. 
 
Many patients report the development of their 
ME and CFS to occur after stressful life events 
(e.g., vehicle accident, surgery) (Becker et al., 
2002; Hatcher & House, 2003; Theorell, 
Blomkvist, Lindh, & Evengard, 1999; Wessely 
et al., 1995). Although the majority of patients 
report an infection to play some role in their 
onset (Anderson, Jason, & Hlavaty, 2014; Butler 
et al., 2001), some patients have no clinical or 
laboratory evidence of viral infection (Farrar, 
Locke, & Kantrowitz, 1995). Hatcher and House 
(2003) found stressful life events—which 
occurred three months prior to ME and CFS—to 
be common. Noting these events is important, as 
psychological strain has been theorized to impair 
the Hypothalamic-Pituitary Adrenal axis (HPA-
axis), which would disturb the 
neuroendocrinological responses in ME and CFS 
patients (Cleare, 2003). When the HPA-axis 
becomes dysregulated and over-produces 
cortisol and dehydroepiandrosterone, a person’s 
immune system may weaken (Cohen, Janicki-
Deverts, & Miller, 2007; Morale et al., 2001); 
thus, stress could prompt the development of 
ME and CFS. 
 
A stress-related onset has often been reported as 
a gradually occurring process (DeLuca et al., 
1997). Because this group is more likely to 
endure difficult life events, they may be more 
inclined to believe they played a role in causing 
their illness (internal attribution), which may 
lead to depressive symptoms (Peterson, 
Schwartz, & Seligman, 1981). For example, if 
someone ascribed their illness to work stress, 
they might take blame for their illness because 
they felt they could have reduced their work 
hours. However, once sick with ME and CFS, 
they no longer believe they have control over 
their symptoms (White et al., 2006). Research 
has suggested that people with an internal 
(psychological) attribution, who also have an 
external locus of control over their ME or CFS, 
will have worse psychological adjustment 
(White et al., 2006). 
 
Congruent with the convoluted nature of ME 
and CFS, many patients attribute their illness to 
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  a combination of infection and stress-related 
factors (Becker et al., 2002; Butler et al., 2001; 
Theorell et al., 1999). These multi-faceted onset 
attributions support theories that ME and CFS 
are heterogeneous in nature (Afari & Buchwald, 
2014). 
 
The goal of this study was to examine how the 
mode of ME and CFS onset impacts patients’ 
presenting symptomatology. While other ME 
and CFS onset modes exist, this study 
investigated the differences between the most 
commonly reported onsets: infectious, stress-
related, and a combined infectious and stress-
related onset (referred to as ‘combined onset’). 
Based on previous research, and the physical 
nature of an infection, we predicted that an 
infectious onset would result in more severe 
symptomatology and impaired physical 
functioning when compared to a stress-related 
onset. Conversely, we predicted that a stress-
related onset would result in worse mental 
functioning when compared to an infectious 
onset. Lastly, we predicted that a combined 
onset would result in worse physical and mental 
functioning, as well as worse symptomatology, 
compared to the other two groups, as the two-
fold effect of both an infection and stress may 
compound impairment. 
 
METHODS	  
PARTICIPANTS	  
Three patient samples were combined and 
utilized: the DePaul sample, the Norway sample, 
and the Newcastle-uponTyne Royal Victoria 
Infirmary sample. Case ascertainment methods 
differed between the samples. Participants in the 
DePaul sample were adults who self-identified 
as having CFS, ME/CFS, or ME; participants in 
the Norway sample were diagnosed with CFS by 
a physician or medical specialist, or came from 
an inpatient medical ward for severely ill 
patients, or were from an outpatient clinic; and 
participants in the Newcastle-uponTyne Royal 
Victoria Infirmary sample were recruited from a 
primary care setting, after completing a medical 
workup. All participants had to meet the Fukuda 
et al. (1994) criteria to be included in the present 
study. 
 
DePaul	  Sample	  
 
Eligibility for inclusion was met with the 
following criteria: an individual needed to be (a) 
between the ages of 18 and 65; (b) literate in 
English; (c) and have a self-reported current 
diagnosis of CFS, ME/CFS, or ME. Recruitment 
occurred in a variety of settings, including posts 
on internet forums, contacting support groups, 
and following up with individuals who 
previously participated in a DePaul study while 
expressing interest in future studies. In addition, 
individuals who had emailed the team with 
interest in future studies were contacted. Three 
options were available for survey completion: an 
electronic survey, a hard-copy survey, or a 
verbal survey over the telephone. Surveys could 
be completed either at home or in-person at 
DePaul University’s Center for Community 
Research. Five-dollar Amazon.com gift cards 
were given to the first 100 individuals who 
completed the survey. 
 
Norway	  Sample	  
 
This sample consisted of patients from four mid-
sized towns in southern Norway, as well as an 
inpatient medical ward and an outpatient clinic 
at a multidisciplinary CFS/ME center. 
Recruitment occurred through healthcare 
professionals, a waiting list for a patient 
education program, and CFS patient 
organizations. Participants needed to be between 
18 and 65 years old and be literate in 
Norwegian. Before participants could be 
included in the sample, they had to complete a 
written informed consent process. 
 
Newcastle	  Sample	  
 
This sample consisted of participants who were 
suspected of having CFS by primary care 
physicians after a complete medical assessment 
at the Newcastle-upon-Tyne Royal Victoria 
clinic. At the clinic, an experienced consultant 
physician collected a comprehensive medical 
history and examined each individual. Those 
who met eligibility criteria completed a written 
informed consent process before being included 
in the sample. They completed the study 
measures by hard copy. 
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MEASURES	  
Medical	   Outcomes	   Study	   36-­‐item	   Short-­‐Form	  
Health	  Survey	  (SF-­‐36	  or	  RAND-­‐36)	  
 
All participants completed the SF-36. This 36-
item measure allows participants to self-report 
their functional and mental health status. Scores 
on 100-point scales are calculated for the 
following domains: physical functioning, role 
physical (a measure of the impact of physical 
health problems on ability to fulfill life roles), 
bodily pain, general health (a measure of global 
perceptions of overall health), social 
functioning, mental health functioning, role 
emotional (a measure of the impact of mental 
health problems on ability to fulfill life roles), 
and vitality (a measure of fatigue/energy). 
Higher scores indicate better health or less 
impact of health on functioning. On this form, 
an example question reads: How true or false is 
each of the following statements for you? I 
expect my health to get worse (Definitely true; 
Mostly true; Don’t know; Mostly false; 
Definitely false). Studies assessing the SF-36 
construction have found adequate internal 
consistency, significant discriminant validity 
among subscales, and substantial differences in 
the pattern of scores between patient and non-
patient populations (McHorney, War Jr, Lu, & 
Sherbourne, 1994). 
	  
The	  DePaul	  Symptom	  Questionnaire	  (DSQ)	  
 
All participants also completed the DSQ (Jason 
et al., 2010). This measure allows participants to 
self-report their illness onset, symptomatology, 
demographics, and medical, occupational, and 
social history. On a five-point Likert-scale, 
participants rated the frequency and severity of 
54 symptoms over the past six months. For 
frequency, the items state “Throughout the past 
6 months, how often have you had this 
symptom?”  (0 = none of the time, 1 = a little of 
the time, 2 = about half the time, 3 = most of the 
time, and 4 = all of the time). For severity, the 
items state “Throughout the past 6 months, how 
much has this symptom bothered you?” (0 = 
symptom not present, 1 = mild, 2 = moderate, 3= 
severe, and 4 = very severe). Frequency and 
severity scores were each multiplied by 25 to 
create 100-point scales. The 100-point frequency 
and severity scores for each symptom were then 
averaged to create one score per symptom.  The 
development of the DSQ was based upon the 
Clinical Canadian Criteria (Carruthers et al., 
2003), which identifies seven symptom domains 
(fatigue/post-exertional malaise, neurological 
dysfunction, sleep dysfunction, pain, autonomic 
dysfunction, immune dysfunction, and 
neuroendocrine dysfunction). Thus, DSQ 
symptom scores are grouped by these seven 
theoretical domains for analysis. Among both 
patient and control groups, the DSQ has 
illustrated good test-retest reliability (Jason, So, 
Brown, Sunnquist, & Evans, 2015) with factors 
evidencing good internal consistency (Brown & 
Jason, 2014). 
	  
ANALYSIS	  
	  
Participants were divided into one of three onset 
groups—infectious, stress, or combined 
infectious and stress—based on their responses 
to the DSQ item: Did your fatigue/energy 
related illness start after you experienced any of 
the following? (Check one or more and please 
specify): An infectious illness, An accident, A 
trip or vacation, An immunization (a shot at 
doctor’s office), Surgery, Severe stress (bad or 
unhappy events), Other (please list), I am not ill. 
 
Although participants could have marked more 
than one answer to the DSQ onset item, they 
were only included in this study if they reported 
an infectious, stress, or combined infectious and 
stress onset. For instance, if a participant 
reported an infectious onset and an onset after a 
trip or vacation, they would be assigned to the 
infectious-only group. Similarly, if a participant 
reported a stress onset and an onset after a trip or 
vacation, they would be assigned to the stress-
only group. The infectious, stress, and combined 
infectious and stress onset groups are the most 
likely precipitating factors of ME and CFS 
(Becker et al., 2002), while events like an 
accident, trip or vacation, an immunization, or 
surgery might precipitate an infection or cause 
stress (e.g., someone contracts an infection while 
on a trip). If, however, a participant reported 
having an infectious and stress onset, they were 
assigned to the combined group. A multivariate 
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  analysis of variance (MANOVA) was used to 
compare these three groups on symptomatology 
and the SF-36 subscales, followed up by 
univariate and post-hoc comparisons when 
indicated. An alpha level of .05 was used for all 
statistical tests.	  
	  
RESULTS	  
SAMPLES	  
The combined sample (DePaul, Newcastle, and 
Norway) consisted of 495 participants. 
However, 101 of these participants were 
excluded because they did not endorse either an 
infectious or stress onset; four of these excluded 
participants endorsed “onset after an accident,” 
four endorsed “after a trip or vacation,” 11 
endorsed “after an immunization,” 17 endorsed 
“after surgery,” and 56 selected “other.” After 
these exclusions, the combined sample was 394 
participants; 151 were included from the DePaul 
sample, 60 were included from the Newcastle 
sample, and 183 were included from the Norway 
sample. These three groups were not 
significantly different on mode of illness onset, 
ethnicity or gender. However, there were 
significant differences between the samples on 
age [F(2, 372) = 22.67, p<.001], education level 
[X2(15, 389) = 178.50,  p<.001], and work status 
[X2(12, 373) =167.14, p<.05]. 
 
The DePaul sample was significantly older than 
the other two samples with a mean age of 51.8, 
compared to the Newcastle sample with a mean 
of 45.9, and the Norway sample with a mean of 
42.4. Regarding educational level achieved, the 
DePaul sample was the most educated, followed 
by the Newcastle sample, and then the Norway 
sample (80%, 53.45%, and 49.17% completed at 
least a standard college degree). Regarding work 
status, a greater percentage of the DePaul 
sample was unemployed compared to the 
Norway sample, and a greater percentage of the 
Norway sample was on disability compared to 
the DePaul sample. 
	  
Table 1 provides demographic information for 
the three onset groups: 213 individuals were 
categorized as “infectious onset,” 59 individuals 
were categorized as “stress onset,” and 122 
individuals were categorized as “combined 
infectious and stress onset.” Statistical analyses  
showed only one significant difference between 
the groups. A chi-squared test found participants 
with a stress-related onset were more likely to 
report having children compared to the 
infectious and combined groups, X2(2, 
391)=9.818, p=.007. The vast majority of 
participants in each group were female, white, 
and on disability. 
	  
FUNCTIONAL	  STATUS	  
Table 2 displays the SF-36 data. A multivariate 
analysis of variance (MANOVA) found that the 
three groups differed overall on these subscales 
[Wilks’ Lamda = .894, F(16, 728)=2.632, 
p<.001]. The univariate tests revealed a 
significant overall difference on general health 
functioning [F(2, 374)=3.982, p=.019], mental 
health functioning [F(2, 374)=8.55, p<.001], and 
role emotional functioning [F(2, 374)=6.247, 
p=.002]. There was a minor violation for 
homogeneity of between-group variance on the 
Role Emotional scale, but Brown-Forsythe F 
and Welch’s F adjustments showed that this had 
no impact on the observed outcome. The other 
subscales were non-significant. Bonferroni post-
hocs revealed that the infectious group had 
significantly worse general health than the stress 
group (p=.019). The combined group neared 
significance (p=.061), reporting worse general 
health functioning than the stress-related group. 
 
The infectious group had significantly better 
mental health functioning than both the stress-
related (p=.004) and combined groups (p=.002). 
Additionally, a Games-Howell post-hoc test was 
conducted on the Role Emotional subscale, as 
this category did not meet the homogeneity of 
variance assumption. This test found that the 
combined group reported the worst functioning 
on the role emotional scale, but was only 
significantly worse than the infectious group (p 
= .004). 
 
 
 
 
 
5
Devendorf et al.: Infectious and Stress-related Onsets in ME and CFS
Published by Via Sapientiae, 2016
	   
 
 
Table 1. Demographics (N= 394) 
  Infectious 
(n=213) 
Stress 
(n=59) 
Combined 
(n=122) 
 
 M (SD) M (SD) M (SD)  
     
Age 46.88 (14.20) 47.53 (10.79) 46.19 (11.92)  
 % (n) % (n) % (n) p 
Sex    .801 
    Male 16.4 (35) 12.1 (7) 17.2 (21)  
    Female  83.6 (178) 87.9 (51) 82.8 (101)  
Race    .661 
    White 97.6 (206) 98.3 (58) 99.2 (121)  
     Asian/Pacific Islander 0.5 (1) 1.7 (1) 0  
     Other 1.9 (4) 0 .8 (1)  
Education     .426 
     Less than high school 5.7 (12) 5.2 (3) 3.3 (4)  
     Some high school 2.4 (5) 0 (0) 0.8 (1)  
     HS degree or GED 21.3 (45) 24.1 (14) 25.8 (31)  
     Partial college   9.0 (19) 13.8 (8) 5.8 (7)  
     Standard college degree 35.5 (75) 39.7 (23) 36.7 (44)  
     Graduate degree 26.1 (55) 17.2 (10) 27.5 (33)  
Marital Status    .758 
     Married/partnered 55.5 (116) 55.9 (33) 51.3 (61)  
     Separated .5 (1) 1.7 (1) 1.7 (2)  
     Widowed 1 (2) 0 (0) 1.7 (2)  
     Divorced 12.4 (26) 18.6 (11) 13.4 (16)  
     Never Married 30.6 (64) 23.7 (14) 31.9 (38)  
Children    .007 
     Yes 46.4 (98) 69.5 (41) 52.1 (63)  
     No 53.6 (113) 30.5 (18) 47.9 (58)  
Work Status    .134 
     On disability 59.7 (120) 67.3 (37) 64.1 (75)  
     Student 5.0 (10) 0 (0) 2.6 (3)  
     Homemaker 2.0 (4) 1.8 (1) 4.3 (5)  
     Retired 10.4 (21) 7.3 (4) 6 (7)  
     Unemployed 7.5 (15) 0 (0) 7.7 (9)  
     Working part-time 9 (19) 16.4 (9) 13.7 (16)  
     Working full-time 6 (12) 7.3 (4) 1.7 (2)  
     
In summary, the infectious group showed the 
worst general health functioning, but the highest 
mental health functioning compared to the other 
groups. On the contrary, the stress-related and 
combined group reported the worst mental 
health functioning. Additionally, the combined  
group showed comparable general health 
functioning to the infectious group; however, 
this finding should be taken with caution as it 
was not statistically significant. Lastly, the 
combined group reported the worst role 
emotional scores. 
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SYMPTOMATOLOGY	  	  
Based on the symptom categories of the Clinical 
Canadian Criteria (Carruthers et al., 2003), the 
symptoms were categorized into the following 
domains for analysis: Fatigue/Post-Exertional 
Malaise (six symptoms), Sleep (six symptoms), 
Pain (seven symptoms), Neurological (13 
symptoms), Autonomic (seven symptoms), 
Neuroendocrine (ten symptoms), and Immune 
(five symptoms). MANOVA was used to 
compare the three groups on the unique 
collection of symptoms from each of the seven 
theoretical symptom domains of the DSQ. The 
three groups were significantly different on the 
Autonomic [Wilks' Lambda=.93, F(2, 
367)=1.904, p=.023] and Immune domains 
[Wilks' Lamda= .947, F(2, 359)=1.943, p=.037]. 
However, the Fatigue/Post- Exertional Malaise, 
Sleep, Pain, Neurological, and Neuroendocrine 
domains were non-significant.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 displays the Autonomic symptoms. The 
univariate tests revealed a significant difference 
between the groups for nausea [F(2, 370)=4.093, 
p=.017] and irregular heartbeats [F(2, 
370)=4.949, p=.008]. Bonferroni post-hoc tests 
found the infectious and combined groups 
experienced worse nausea and irregular 
heartbeats than the stress group. The items 
dizziness or fainting [F(2, 370)=2.976, p=.052] 
and unsteady on one’s feet [F(2, 370)=2.595, 
p=.076] approached significance.  
 
Table 4 presents the Immune items. Univariate 
tests revealed a significant difference between 
the groups for sensitivity to smells/foods, etc. 
[F(2, 359)=3.482, p=.032] and flu-like 
symptoms [F(2, 359)=4.452, p=.012]. 
Bonferroni post-hoc tests found the combined 
group to experience 
 
 
 
Table 3. Differences in autonomic symptoms across modes of illness onset (N=370) 
 
 Infectious 
(n=198) 
Stress 
(n=53) 
Combined 
(n=119) 
p 
 M (SD) M (SD) M (SD)  
Bladder problems 27.90 (30.24) 33.73 (38.10) 29.90 (32.72) .418 
Irritable bowel problems 47.16 (31.72) 46.70 (33.72) 52.84 (34.84) .291 
Nausea 36.93 (26.81)a 25.71 (23.18)ab 37.50 (28.79)b .017 
Unsteady on your feet 43.24 (28.40) 33.73 (25.31) 39.81 (27.18) .076 
Shortness of breath 41.22 (28.10) 34.67 (31.26) 40.91 (28.34) .317 
Dizziness or fainting 42.42 (27.73) 32.78 (24.42) 42.33 (25.37) .052 
Irregular heartbeats 33.84 (28.21)a 23.35 (23.52)ab 37.92 (29.65)b .008 
ab Similar letters note significant differences  
 
Table 2. Differences in functioning (SF-36 subscales) across modes of illness onset (N = 374) 
 Infectious 
(n=201) 
Stress 
(n=57) 
Combined 
(n=116) 
p 
 M (SD) M (SD) M (SD)  
Physical Functioning 36.25 (23.49) 42.10 (19.45) 37.05 (22.67) .223 
Role Physical  7.42 (20.03) 5.70 (18.30) 4.53 (12.60) .366 
Bodily Pain 40.12 (22.83) 34.71 (21.63) 40.21 (23.48) .256 
General Health  26.87 (15.61)a 33.61 (17.42)a 27.54 (16.36) .019 
Social Functioning 25.50 (23.01) 27.85 (21.39) 22.61 (22.45) .764 
Mental Health 74.02 (16.45)ab 65.84 (18.14)a 67.36 (16.87)b <.001 
Role Emotional 82.59 (34.81)a 71.93 (41.21) 67.24 (43.07)a .002 
Vitality  18.18 (15.86) 19.36 (15.61) 16.89 (15.21) .578 
ab Similar letters note significant differences  
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Table 4. Differences in immune symptoms across modes of illness onset (N=359) 
 Infectious 
(n=194) 
Stress 
(n=51) 
Combined 
(n=114) 
p 
 M (SD) M (SD) M (SD)  
Sore throat 39.82 (27.55) 35.04 (23.32) 41.78 (27.47) .335 
Lymph nodes 40.08 (30.35) 32.84 (28.61) 35.42 (27.47) .198 
Fever 20.72 (24.50) 20.10 (23.19) 19.96 (23.74)  .961 
Flu-like symptoms 56.96 (25.76)a 47.06 (26.53)ab 60.09 (26.39)b  .012 
Sensitivity to smells/foods/ 
medications/ chemicals 
44.39 (36.10) 35.05 (35.88)a 50.82 (35.60)a .032 
ab Similar letters note significant differences  
significantly worse sensitivity problems 
compared to the stress group, but not the 
infectious group. Both the infectious and 
combined group reported significantly worse 
flu-like symptoms compared to the stress group. 
	  
DISCUSSION	  
	  
This study adds to the literature of predicting the 
prognosis of ME and CFS based upon 
knowledge of illness onset. Previous work has 
shown that illness attribution (physical vs. 
psychological), illness duration, an 
internalization of symptoms, a psychiatric co-
morbidity, and stressful life events play a role in 
a patient’s outcome. Given these findings, we 
hypothesized that an infectious onset would lead 
to different levels of symptom impairment 
compared to a stress-related onset. Specifically, 
we predicted that an infectious onset would lead 
to worse physical well-being and 
symptomatology, while a stress-related onset 
would lead to worse mental well-being. Further, 
we predicted that a combined infectious and 
stress-related onset would compound 
symptomatology, perhaps limiting one’s ability 
to cope, resulting in the worst impairment for 
both physical and mental well-being, and more 
severe symptomatology. 
  
The findings lend some support to these 
hypotheses. Analyses showed the infectious 
group reported the most impairment for general 
health functioning—which relates to the 
susceptibility of getting or feeling sick (e.g. “I 
seem to get sick more than most people”)—in 
comparison to the stress-related group. This data 
is congruous with the notion that people with an 
infectious onset could still be suffering from the 
ramifications of a virus or bacterium (Lorusso et 
al., 2009). Although not statistically significant 
from the other two groups, the combined group 
also reported impairment for general health 
functioning 
 
The data also support our hypothesis that a 
stress-related and combined onset would result 
in worse mental well-being compared to an 
infectious onset. For the mental health subscale, 
both the stress-related and combined groups 
reported more impairment than the infectious 
group. This data corroborates prior research that 
stressful life events and the internalization of 
symptoms may hamper one’s ability to 
psychologically cope. However, only the 
combined group experienced more impairment 
on the role emotional subscale compared to the 
infectious group; this finding also supports our 
hypothesis that the combined group would 
report the worst overall impairment in mental 
well-being. These findings suggest that the two-
fold factor of contracting an infection—and 
experiencing life stress—could increase the risk 
for emotional impairment over time 
 
Furthermore, we found differences between 
these onset groups within the autonomic and 
immune symptom domains. As predicted, the 
infectious and combined groups reported worse 
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  autonomic and immune symptomatology than 
the stress group. Nausea, irregular heartbeats, 
and flu-like symptoms were found to be 
significantly worse in the infectious and 
combined groups; the combined group also had 
worse sensitivity to 
smells/foods/medications/chemicals than the 
stress group. Although non-significant, the 
infectious and combined groups reported worse 
impairment for the dizziness or fainting 
symptom. Because this symptom relates to 
general health functioning (e.g. feeling sick), 
and may co-occur with an infection, researchers 
and physicians should be cognizant that this 
symptom could be worse—or more prevalent—
in patients with an infectious onset. Taken as a 
whole, these results support the speculation that 
patients with an infectious onset could be 
affected by an overactive immune system 
(Lorusso et al., 2009). 
 
These findings illustrate that the mode of onset 
for ME and CFS could play a factor in a 
patient’s prognosis. An infectious onset might 
lead to worse physical and somatic symptoms, 
while a stress onset might lead to worse 
psychological functioning. Therefore, both 
physicians and researchers should make note of 
illness onset when working with patients.  The 
field’s focus on psychological factors has 
frustrated many patients with ME and CFS. 
Patients with ME and CFS have commonly 
expressed dissatisfaction with their physicians 
regarding stigma and inadequate treatment 
(Åsbring & Närvänen, 2002; Dickson, Knussen, 
& Flowers, 2007). In the past, patients have 
reproached physicians for not believing ME and 
CFS to be an organic illness (Deale & Wessely, 
2001). Therefore, tailoring treatments for this 
diverse patient population is of great importance. 
 
The present study’s limitations must also be 
noted. We did not apply psychiatric exclusions 
when determining which participants to include 
in the present study. A comorbid psychiatric 
illness might impact a participant’s functioning 
and illness experience, and we were unable to 
account for this when comparing onset groups. 
A second limitation is the method of classifying 
patients into the three onset groups. Although 
patients could have reported multiple types of 
onset, we categorized only into an infectious 
onset, stress-related onset, and a combined 
onset. For instance, a participant who listed both 
infectious onset and got their illness after 
vacation would be sorted into the infectious 
group. This decision was made based on the 
previous research, as these three onsets appear to 
be the most commonly endorsed triggers for the 
illness (Afari & Buchwald, 2014; Becker et al., 
2002; White et al., 2006). Furthermore, the other 
onsets (e.g. an accident, trip or vacation, 
immunization, surgery) may commonly co-occur 
with an infectious or stress onset. For instance, a 
patient might have had surgery, experienced 
stress because of the surgery, and then 
contracted ME and CFS.  
 
Additionally, the present study included 
participants from three unique samples that were 
recruited differently and had both demographic 
similarities and differences. The resulting 
combined sample was thus not homogeneous, 
and it may be more appropriate to study 
subsamples of patients stratified by case 
ascertainment method in the future. We selected 
to combine these groups to allow for greater 
statistical power in our subsequent analyses. 
Notably, when participants were categorized 
into the three onset groups, the resulting groups 
were comparable on almost all demographic 
outcomes. Additionally, our distribution of the 
three illness onset groups is consistent with other 
research samples (Becker et al., 2002; Salit, 
1997; White et al., 2006). About 68% of our 
sample believed an infection played some role in 
their onset, and 37% believed stress played some 
role. White and colleagues (2006) found 61% of 
their sample attributed their illness to either a 
flu, virus, bacteria, or infection, and 43% 
attributed their illness to either stress, overwork, 
or over activity. Becker and colleagues (2002) 
also identified infections to be combined with 
non-infectious stressors, such as psychological 
stress, in the onset of ME and CFS. Finally, this 
study relied on self-report data, and thus, there 
was no outside, objective documentation of the 
participants’ illness onset.  
 
Over the years, findings regarding the onset of 
ME and CFS and subsequent functioning and 
symptomatology have been equivocal, and the 
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  illness experiences amongst patients have been 
variable. However, by investigating ME and 
CFS onset, we may gain a better understanding 
of a patient’s illness progression, which may 
inform the development and implementation of 
treatments. The findings of this study 
corroborate prior research. Future research 
should continue investigating the differences 
among patients based on illness onset, as well as 
other factors (e.g., psychiatric co-morbidity). 
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